All Stories

  1. Too late, too often: missed opportunities in male bone health: a real-world portrait from a 14-year specialist referral experience
  2. Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype
  3. The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies
  4. Value of repeated US-guided fine-needle aspiration (US-FNAB) in the follow-up of benign thyroid nodules: a real-life study based on the MoCyThy (Modena’s Cytology of the Thyroid) DATABASE with a revision of the literature
  5. Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV
  6. Semen Analysis in “Urology-Naïve” Patients: A Chance of Uroandrological Screening in Young Males
  7. Qualitative and quantitative analysis of doctor–patient interactions during andrological consultations
  8. COVID-19 lockdown negatively impacted on adherence to denosumab therapy: incidence of non-traumatic fractures and role of telemedicine
  9. How Much Vitamin D is Too Much? A Case Report and Review of the Literature
  10. The Prevalence of Hypogonadism and the Effectiveness of Androgen Administration on Body Composition in HIV-Infected Men: A Meta-Analysis
  11. Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient
  12. Sexual Dysfunction: A Neglected and Overlooked Issue in Adult GH Deficiency: The Management of AGHD Study
  13. The hypothalamic–pituitary–adrenal and -thyroid axes activation lasting one year after an earthquake swarm: results from a big data analysis
  14. Late Onset Hypogonadism (LOH): bone health
  15. Follicle-Stimulating Hormone (FSH) Action on Spermatogenesis: A Focus on Physiological and Therapeutic Roles
  16. Phenotype of the Adulthood
  17. Reliability of calcium–phosphorus (Ca/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca–P disorders
  18. Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro
  19. Relative hyperestrogenism in Klinefelter Syndrome: results from a meta-analysis
  20. Could chronic Vardenafil administration influence the cardiovascular risk in men with type 2 diabetes mellitus?
  21. Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS)
  22. EAA clinical guideline on management of bone health in the andrological outpatient clinic
  23. Probiotics Ingestion Does Not Directly Affect Thyroid Hormonal Parameters in Hypothyroid Patients on Levothyroxine Treatment
  24. Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism
  25. Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis
  26. The steroid response to human chorionic gonadotropin (hCG) stimulation in men with Klinefelter syndrome does not change using immunoassay or mass spectrometry
  27. Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders
  28. Growth hormone deficiency and human immunodeficiency virus
  29. Aging and sex hormones in males
  30. Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients
  31. Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism
  32. Use of l-Arginine with Growth Hormone-Releasing Hormone (GHRH) and the Endocrine Response
  33. Effects of chronic administration of the phosphodiesterase inhibitor vardenafil on serum levels of adrenal and testicular steroids in men with type 2 diabetes mellitus
  34. Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography–tandem mass spectrometry
  35. Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
  36. Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial
  37. Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study
  38. Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry
  39. Erectile Dysfunction Is Common among Men with Acromegaly and Is Associated with Morbidities Related to the Disease
  40. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study
  41. High-Resolution Melting Is a Sensitive, Cost-Effective, Time-Saving Technique for BRAF V600E Detection in Thyroid FNAB Washing Liquid: A Prospective Cohort Study
  42. The Endocrine Role of Estrogens on Human Male Skeleton
  43. Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients
  44. Hypogonadism in the HIV-Infected Man
  45. Testosterone Supplementation and Sexual Function: A Meta-Analysis Study
  46. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution
  47. Male sexual dysfunction and HIV—a clinical perspective
  48. The Diagnostic Value of Calcitonin Measurement in Wash-Out Fluid from Fine-Needle Aspiration of Thyroid Nodules in the Diagnosis of Medullary Thyroid Cancer
  49. Inverse Correlation Between Vascular Calcification and Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients
  50. Prevalence of Olfactory and Other Developmental Anomalies in Patients with Central Hypogonadotropic Hypogonadism
  51. Erectile Dysfunction Is More Common in Young to Middle‐Aged HIV‐Infected Men than in HIV‐Uninfected Men
  52. Erectile Dysfunction Is Not a Mirror of Endothelial Dysfunction in HIV‐Infected Patients
  53. Propylthiouracil-Induced Interstitial Pneumonia in a Caucasian Woman with Amiodarone-Induced Thyrotoxicosis
  54. Clinical and radiological evidence of the recurrence of reversible pegvisomant-related lipohypertrophy at the new site of injection in two women with acromegaly: a case series
  55. GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls
  56. Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era
  57. Hormonal Regulation of Male Sexual Desire: The Role of Testosterone, Estrogen, Prolactin, Oxytocin, Vasopressin, and Others
  58. Lateralization of Calcitonin Measurements in the Wash-Out Fluid from Thyroid Fine-Needle Aspiration: A Useful Tool for the Diagnosis of C-Cell-Hyperplasia?
  59. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection
  60. Ultrasound Mirror Artifact of a Thyroid Nodule by Trachea Mimicking a Tracheal Mass
  61. Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection
  62. Tall Stature without Growth Hormone: Four Male Patients with Aromatase Deficiency
  63. The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency
  64. Aromatase deficiency in men: a clinical perspective
  65. Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: Are these Two Conditions Associated?
  66. Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men
  67. The Effects of Citalopram and Fluoxetine on Sexual Behavior in Healthy Men: Evidence of Delayed Ejaculation and Unaffected Sexual Desire. A Randomized, Placebo‐Controlled, Double‐Blind, Double‐Dummy, Parallel Group Study
  68. 21-Hydroxylase Deficiency and Klinefelter Syndrome in an Adult Man: Striking a Balance Between Androgen Excess and Insufficiency
  69. A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment
  70. Human models of aromatase deficiency
  71. Late-Onset Triple A Syndrome: A Risk of Overlooked or Delayed Diagnosis and Management
  72. Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men
  73. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome
  74. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: Evidences of a priming effect of estrogen for sex steroids action on bone
  75. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback
  76. Sildenafil Improves Sleep-Related Erections in Hypogonadal Men: Evidence From a Randomized, Placebo-Controlled, Crossover Study of a Synergic Role for Both Testosterone and Sildenafil on Penile Erections
  77. Aromatase is differentially expressed in peripheral blood leukocytes from children, and adult female and male subjects
  78. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology
  79. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism
  80. Estrogens in males: what have we learned in the last 10 years?
  81. Dysmetabolic Syndrome in a Man with a Novel Mutation of the Aromatase Gene: Effects of Testosterone, Alendronate, and Estradiol Treatment
  82. The Apparent Paradox of Tall Stature with Hypopituitarism: New Insights from an Old Story
  83. Bilateral osteonecrosis of the femoral head in an adult man affected by congenital estrogen deficiency
  84. Short-Term Suppression of GH and IGF-I Levels Improves Gonadal Function and Sperm Parameters in Men with Acromegaly
  85. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men
  86. Pituitary Function in a Man with Congenital Aromatase Deficiency: Effect of Different Doses of Transdermal E2 on Basal and Stimulated Pituitary Hormones
  87. Congenital estrogen deficiency: in search of the estrogen role in human male reproduction
  88. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency
  89. Aromatase Inhibitors in Pubertal Boys: Clinical Implications
  90. Clinical implications and management of oestrogen deficiency in the male
  91. Estrogen Replacement Therapy in a Man with Congenital Aromatase Deficiency: Effects of Different Doses of Transdermal Estradiol on Bone Mineral Density and Hormonal Parameters
  92. Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency
  93. Oestrogen deficiency in men: where are we today?
  94. Pathophysiology of estrogen action in men